Goldman Sachs Group Inc Lumos Pharma, Inc. Transaction History

Goldman Sachs Group Inc

  • $580 Billion
  • Q2 2024

A detailed history of Goldman Sachs Group Inc transactions in Lumos Pharma, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 406,611 shares of LUMO stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
406,611
Previous 406,612 0.0%
Holding current value
$1.78 Million
Previous $1.15 Million 17.71%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$2.19 - $3.04 $2 - $3
-1 Reduced -0.0%
406,611 $943,000
Q1 2024

May 15, 2024
BUY
$2.64 - $3.22 $2 - $3
1 Added 0.0%
406,612 $1.15 Million
Q4 2023

Feb 13, 2024
BUY
$2.81 - $4.27 $148 - $226
53 Added 0.01%
406,611 $1.29 Million
Q3 2023

May 14, 2024
SELL
$2.63 - $3.49 $139 - $184
-53 Reduced 0.01%
406,558 $1.34 Million
Q3 2023

Nov 14, 2023
SELL
$2.63 - $3.49 $1,015 - $1,347
-386 Reduced 0.09%
406,558 $1.34 Million
Q2 2023

May 14, 2024
BUY
$3.01 - $4.38 $1,188 - $1,730
395 Added 0.1%
406,944 $1.34 Million
Q2 2023

Aug 14, 2023
BUY
$3.01 - $4.38 $1,188 - $1,730
395 Added 0.1%
406,944 $1.34 Million
Q1 2023

May 14, 2024
SELL
$3.16 - $4.0 $198,504 - $251,272
-62,818 Reduced 13.38%
406,549 $1.35 Million
Q1 2023

May 11, 2023
SELL
$3.16 - $4.0 $198,504 - $251,272
-62,818 Reduced 13.38%
406,549 $1.35 Million
Q4 2022

May 14, 2024
SELL
$3.05 - $9.52 $349,313 - $1.09 Million
-114,529 Reduced 19.61%
469,367 $1.69 Million
Q4 2022

Feb 13, 2023
SELL
$3.05 - $9.52 $349,313 - $1.09 Million
-114,529 Reduced 19.61%
469,367 $1.69 Million
Q3 2022

May 14, 2024
BUY
$7.35 - $9.05 $1.68 Million - $2.06 Million
227,909 Added 64.02%
583,896 $5.17 Million
Q3 2022

Nov 10, 2022
BUY
$7.35 - $9.05 $1.68 Million - $2.06 Million
227,909 Added 64.02%
583,896 $0
Q2 2022

May 14, 2024
SELL
$6.68 - $9.39 $338,168 - $475,359
-50,624 Reduced 12.45%
355,987 $2.74 Million
Q2 2022

Aug 15, 2022
SELL
$6.68 - $9.39 $140 - $197
-21 Reduced 0.01%
355,987 $2.74 Million
Q1 2022

May 16, 2022
BUY
$6.58 - $10.09 $118 - $181
18 Added 0.01%
356,008 $3.35 Million
Q4 2021

Feb 14, 2022
BUY
$6.84 - $10.04 $2.43 Million - $3.57 Million
355,990 New
355,990 $2.47 Million

Others Institutions Holding LUMO

# of Institutions
38
Shares Held
2.88M
Call Options Held
0
Put Options Held
0
View Full List

About LUMOS PHARMA, INC.

LUMO Quotes by TradingView
  • Ticker LUMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,396,070
  • Market Cap $36.7M
  • Description
  • Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...
More about LUMO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email